Literature DB >> 1644297

A protein-binding site in the c-myc promoter functions as a terminator of RNA polymerase II transcription.

S Roberts1, T Purton, D L Bentley.   

Abstract

Termination of transcription not only allows polymerases that have completed RNA synthesis to recycle, but it also has important functions in transcriptional regulation and in preventing promoter interference. The molecular basis for termination by RNA polymerase II (pol II) is unclear, however. We have identified a termination site in the promoter region of the c-myc gene, whose function correlates with DNA binding by a nuclear factor. When the c-myc gene was transcribed in injected Xenopus oocytes or a HeLa nuclear extract, a fraction of RNA initiated at the first promoter, P1, terminated at two positions, T1A and T1B, which flank the TATA box of the second promoter, P2. T1B is a T-rich sequence that resembles previously identified attenuation sites, but T1A appears to represent a different class of termination site. T1A is situated approximately 10 bases upstream of an element that overlaps the P2 TATA box. Mutagenesis of this element affected both the efficiency and the position at which termination occurred. A 28-base sequence including this element caused a low level of termination when inserted into the alpha-globin gene in either orientation. This sequence bound a factor called TBF I (terminator-binding factor), whose binding specificity correlated with T1A terminator function. We suggest that TBF I may function as a pol II termination factor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644297     DOI: 10.1101/gad.6.8.1562

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  10 in total

1.  Tip110 protein binds to unphosphorylated RNA polymerase II and promotes its phosphorylation and HIV-1 long terminal repeat transcription.

Authors:  Weina Zhao; Ying Liu; Khalid Amine Timani; Johnny J He
Journal:  J Biol Chem       Date:  2013-11-11       Impact factor: 5.157

2.  3' Processing and termination of mouse histone transcripts synthesized in vitro by RNA polymerase II.

Authors:  X Gu; W F Marzluff
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

3.  Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts.

Authors:  F Pessler; P S Pendergrast; N Hernandez
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

4.  RNA footprint mapping of RNA polymerase II molecules stalled in the intergenic region of polyomavirus DNA.

Authors:  F Brabant; N H Acheson
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

Review 5.  Regulation of eukaryotic gene expression by transcriptional attenuation.

Authors:  S Wright
Journal:  Mol Biol Cell       Date:  1993-07       Impact factor: 4.138

6.  Mutation of large T-antigen-binding site A, but not site B or C, eliminates stalling by RNA polymerase II in the intergenic region of polyomavirus DNA.

Authors:  J Bertin; N A Sunstrom; N H Acheson
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters.

Authors:  E DesJardins; N Hay
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

8.  Sequences in the human c-myc P2 promoter affect the elongation and premature termination of transcripts initiated from the upstream P1 promoter.

Authors:  T Meulia; A Krumm; C Spencer; M Groudine
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

9.  MAZ-dependent termination between closely spaced human complement genes.

Authors:  R Ashfield; A J Patel; S A Bossone; H Brown; R D Campbell; K B Marcu; N J Proudfoot
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

10.  Poly(A) signals and transcriptional pause sites combine to prevent interference between RNA polymerase II promoters.

Authors:  J Eggermont; N J Proudfoot
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.